EICHOR
● Recruiting
A Study of BG-C477 in Participants With Advanced Solid Tumors
Condition: Advanced Solid Tumors · Sponsor: BeOne Medicines
About this study
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of BG-C477 alone and in combination with anticancer agents in participants with selected advanced solid tumors.
This description comes directly from the study's public registry record.
Talk to the study team
Study Director · 1.877.828.5568 · clinicaltrials@beonemed.com
Always discuss trial participation with your own doctor first.
Locations (58)
| City of Hope Phoenix Cancer Center | Goodyear, Arizona, United States | Recruiting |
| City of Hope National Medical Center | Duarte, California, United States | Recruiting |
| University of Colorado Cancer Center | Aurora, Colorado, United States | Recruiting |
| Yale University Yale Cancer Center | New Haven, Connecticut, United States | Recruiting |
| Osf Saint Francis Medical Center | Peoria, Illinois, United States | Recruiting |
| The University of Kansas Cancer Center | Westwood, Kansas, United States | Recruiting |
| John Theurer Cancer Center Hackensack University Medical Center | Hackensack, New Jersey, United States | Recruiting |
| The University of Texas Md Anderson Cancer Center | Houston, Texas, United States | Recruiting |
| Texas Oncology Longview | Longview, Texas, United States | Recruiting |
| Blacktown Cancer and Haematology Centre | Blacktown, New South Wales, Australia | Recruiting |
| Northern Beaches Hospital | Frenchs Forest, New South Wales, Australia | Recruiting |
| Sunshine Coast University Private Hospital | Birtinya, Queensland, Australia | Recruiting |
+ 46 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06596473